DGAP-News

B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG successfully concludes first Annual General Meeting as a stock listed company

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): AGM/EGM B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG successfully concludes first Annual General Meeting as a stock listed company 09.03.2017 / 18:41 The issuer is solely responsible for the content of this announcement. BRAIN AG successfully concludes first Annual General Meeting as a stock listed company

• New Supervisory Board members with high approval elected
• 
  
• Change of the auditor as planned
• 
  
• New Authorized Capital ensures high flexibility for corporate finance transactions
• 
  
• Frank Goebel new Chief Financial Officer (CFO)
• 
  

Zwingenberg, 9 March 2017: B.R.A.I.N. Biotechnology Research and Information Network AG ("BRAIN AG", ISIN DE0005203947 / WKN 520394) today successfully held its first Annual General Meeting since the IPO on February 9, 2016. At the Annual General Meeting 70,77% of the total share capital, the latter accounting for 16,414,348 shares of BRAIN AG, was represented. All agenda items, including the new election of four Supervisory Board members, the election of a new auditor as well as the creation of a new Authorized Capital, were resolved by a large majority of the participating shareholders. After the return of Dr Georg Kellinghusen to the Supervisory Board, Mangement Board member Frank Goebel becomes CFO of BRAIN AG as previously announced.

Dr Juergen Eck (CEO) particularly focused his speech on last year's IPO and the business strategy of the BRAIN Group, referring to BRAIN's two segments. Since the IPO, both segments were expanded further and new milestones have been achieved. As an example, he mentioned the start of the DOLCE program for the production of natural sweeteners with its high growth potential.